Related Experiment Videos
Total ischemic burden: effect of vasoactive agents
1Cardiology Division, State University of New York Health Sciences Center, Stony Brook 11794.
Insights
Effective treatment of myocardial ischemia requires documenting all episodes and understanding underlying mechanisms. Vasoactive drugs like nitrates and calcium blockers improve coronary blood flow, proving valuable in clinical trials for managing ischemic heart conditions.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Myocardial ischemia, both symptomatic and silent, poses a significant clinical challenge.
- Understanding the pathophysiology, including vasoconstriction, is crucial for effective treatment.
- Prognosis assessment relies on comprehensive documentation of ischemic events.
Purpose of the Study:
- To highlight the importance of documenting all myocardial ischemia episodes.
- To emphasize the role of vasoconstriction in myocardial ischemia.
- To identify clinically useful vasoactive drugs for managing myocardial ischemia.
Main Methods:
- Review of experimental and clinical data on myocardial ischemia.
- Analysis of the role of vasoactive drugs in coronary circulation.
- Evaluation of nitrates and calcium blockers, particularly nifedipine.
Main Results:
- Adequate documentation of painful and painless myocardial ischemia is essential for treatment.
- Vasoconstriction is a key factor in many myocardial ischemia episodes.
- Nitrates and calcium blockers, especially nifedipine, demonstrate significant clinical utility.
Conclusions:
- Vasoactive drugs that enhance coronary blood flow are vital for treating myocardial ischemia.
- Nitrates and calcium blockers represent valuable therapeutic options for managing myocardial ischemia.
- Effective management necessitates a thorough understanding of ischemia and its treatment modalities.
Abstract:
Treatment of the total ischemic burden is dependent on adequate documentation of both painful and painless episodes of myocardial ischemia, an understanding of the pathophysiologic mechanisms involved, and knowledge of prognosis for affected patients. Because a vasoconstrictive component appears to be an important element in the genesis of many episodes of myocardial ischemia, those vasoactive drugs that produce increased flow in the coronary circulation should be clinically useful. Nitrates and calcium blockers--especially nifedipine--have been found to be particularly valuable in this regard in both experimental and clinical trials.